Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria
- DOI
- 10.1111/all.70181
- Published
- 2025-12-08
- Container
- Allergy
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/all.70181,
title = {Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria},
author = {Ana M. Gimenez‐Arnau and Marcus Maurer and Adam Reich and Chia‐Yu Chu and Diana Deleanu and Gordon Sussman and Jorge Sanchez and Knut Brockow and Koremasa Hayama and Michihiro Hide and Mohamed Denguezli and Raisa Meshkova and Roberta F. J. Criado and Sarbjit Saini and Solange Valle and Eva Hua and Pengpeng Wang and Alis Burciu and Isabelle Indermuehle and Vineeth Varanasi and Yolandi Joubert and Thomas Severin and Manmath Patekar},
year = {2025},
journal = {Allergy},
doi = {10.1111/all.70181},
url = {https://doi.org/10.1111/all.70181}
}RIS
TY - JOUR TI - Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria AU - Ana M. Gimenez‐Arnau AU - Marcus Maurer AU - Adam Reich AU - Chia‐Yu Chu AU - Diana Deleanu AU - Gordon Sussman AU - Jorge Sanchez AU - Knut Brockow AU - Koremasa Hayama AU - Michihiro Hide AU - Mohamed Denguezli AU - Raisa Meshkova AU - Roberta F. J. Criado AU - Sarbjit Saini AU - Solange Valle AU - Eva Hua AU - Pengpeng Wang AU - Alis Burciu AU - Isabelle Indermuehle AU - Vineeth Varanasi AU - Yolandi Joubert AU - Thomas Severin AU - Manmath Patekar PY - 2025 JO - Allergy DO - 10.1111/all.70181 UR - https://doi.org/10.1111/all.70181 ER -
APA
Gimenez‐Arnau, A. M., Maurer, M., Reich, A., Chu, C., Deleanu, D., Sussman, G., Sanchez, J., Brockow, K., Hayama, K., Hide, M., Denguezli, M., Meshkova, R., Criado, R. F. J., Saini, S., Valle, S., Hua, E., Wang, P., Burciu, A., Indermuehle, I., Varanasi, V., Joubert, Y., Severin, T., & Patekar, M. (2025). Long‐Term Efficacy and Safety of Ligelizumab as Re‐Treatment in Patients With Chronic Spontaneous Urticaria. Allergy. https://doi.org/10.1111/all.70181
Source records
- crossref · retrieved 2026-09-26T00:03:07.813Z